Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway

Overview of attention for article published in Frontiers in Pharmacology, January 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential

Article in Bioorganic & Medicinal Chemistry (September 2024)

Natural products: A potential immunomodulators against inflammatory-related diseases

Article in Inflammopharmacology (August 2024)

Huang Lian Jie Du Decoction enhances the anti-tumor efficacy of immune checkpoint inhibitors by activating TLR7/8 signalling in melanoma

Article in BMC Complementary Medicine and Therapies (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.